Marker Therapeutics, Inc. (MRKR)
0.8928
0.00 (0.00%)
USD |
NASDAQ |
Nov 06, 16:00
0.9166
+0.02
(+2.67%)
After-Hours: 20:00
Marker Therapeutics Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 6.824M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 7.226M |
| June 30, 2022 | 10.82M |
| March 31, 2022 | 11.04M |
| December 31, 2021 | 11.25M |
| September 30, 2021 | 11.43M |
| June 30, 2021 | 11.57M |
| March 31, 2021 | 11.72M |
| December 31, 2020 | 11.87M |
| September 30, 2020 | 11.95M |
| June 30, 2020 | 9.025M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2261M |
| December 31, 2019 | 0.2802M |
| September 30, 2019 | 0.3335M |
| June 30, 2019 | 0.3852M |
| March 31, 2019 | 0.4352M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 7.236M |
| ACADIA Pharmaceuticals, Inc. | 57.32M |
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Anika Therapeutics, Inc. | 24.56M |
| Savara, Inc. | 30.11M |